TScan Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:TCRX) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 188.11 M199.09 M272.15 M371.12 M228.79 M 총 부채 27.33 M99.66 M121.28 M130.15 M105.67 M 자본금 총액 160.78 M99.43 M150.87 M240.97 M123.12 M 총 부채 및 주주자본 188.11 M199.09 M272.15 M371.12 M228.79 M 총부채 —29.29 M26.7 M32.07 M32.53 M 순부채 —29.29 M26.7 M32.07 M-119.87 M

뉴스

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com

Tscan Therapeutics Q1 실적, 수익 예상치를 넘어

Tscan Therapeutics earnings beat by $0.09, revenue topped estimates

TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates

TScan completes enrollment in trial cohort, receives FDA clearance

Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates

Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?

Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Tscan 테라퓨틱스, ASH 행사 후 BTIG ’중립’ 등급 유지